A hidden structure inside the cell is rewriting how scientists understand leukemia. Beneath the microscope, what looked like disorder turned out to follow a simple physical rule—one that connects several major mutations behind the disease.
PHILADELPHIA, Nov. 4, 2025 /PRNewswire/ — X-Biomedical today announced the launch of GoScope™, a portable, AR- and AI-enabled microscope system designed for surgeons, dental professionals, and educators. GoScope is the first portable digital 3D microscope system to combine voice-controlled zoom and video capture with real-time telestration¹, bringing advanced visualization, documentation, and patient communication to everyday clinical and educational settings.
https://medicalxpress.com/news/2025-11-ultrasound-technology-invasively-blood-viscosity.html
Researchers at the Madrid Institute for Advanced Studies in Nanoscience (IMDEA Nanociencia) and the National Center for Biotechnology (CNB-CSIC) have developed an innovative technique to destroy cancer cells by inducing a cascade that spreads throughout the tumor.
MIT engineers have developed a flexible drug-delivery patch that can be placed on the heart after a heart attack to help promote healing and regeneration of cardiac tissue.
Fiber-optic technology revolutionized the telecommunications industry and may soon do the same for brain research.
For the first time, a research team led by the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC has mapped the genetic architecture of a crucial part of the human brain known as the corpus callosum—the thick band of nerve fibers that connects the brain’s left and right hemispheres. The findings open new pathways for discoveries about mental illness, neurological disorders and other diseases related to defects in this part of the brain.
Around the globe, heart disease remains one of the top causes of death. Once patients begin to suffer from serious heart problems, like heart attacks and heart failure, the heart muscles become damaged and are difficult to treat and repair.
The panels employ PCR techniques to test for numerous gastrointestinal bacterial pathogens using one stool swab.
Having already submitted an application with the FDA, Tulyp is now eyeing a Series A financing round to capture more clinical data and advance R&D.